| CAS NO: | 130606-60-9 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| Cas No. | 130606-60-9 |
| 别名 | 盐酸地尔硫卓杂质D |
| Canonical SMILES | CC(O[C@@H]1[C@@](C2=CC=C(C=C2)OC)([H])SC3=CC=CC=C3N(C1=O)CCNC)=O.Cl |
| 分子式 | C21H24N2O4S ? HCl |
| 分子量 | 437 |
| 溶解度 | Chloroform: soluble,DMSO: soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | N-desmethyl Diltiazem is an active metabolite of the calcium channel inhibitor diltiazem.1It is formed from diltiazem by the cytochrome P450 (CYP) isoforms CYP3A4, CYP3A5, and CYP3A7.2N-desmethyl Diltiazem binds to isolated rat cerebral cortex homogenates (IC50= 323 nM) and inhibits spontaneous contractions in isolated rat portal veins (IC50= 489 nM).1It has been found as a contaminant in fresh water.3 1.Schoemaker, H., Hicks, P.E., and Langer, S.Z.Calcium channel receptor binding studies for diltiazem and its major metabolites: Functional correlation to inhibition of portal vein myogenic activityJ. Cardiovasc. Pharmacol.9(2)173-180(1987) 2.Williams, J.A., Ring, B.J., Cantrell, V.E., et al.Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7Drug Metab. Dispos.30(8)883-891(2002) 3.Marshall, M.M., and McCluney, K.E.Mixtures of co-occurring chemicals in freshwater systems across the continental USEnviron. Pollut.268(Pt. B)115793(2021) |
m.cnreagent.com